135 related articles for article (PubMed ID: 8961473)
1. Staphylococcal bacteremia in cancer patients: risk factors and outcome in 134 episodes prior to and after introduction of quinolones into infection prevention in neutropenia.
Kukuckova E; Spanik S; Ilavska I; Helpianska L; Oravcova E; Lacka J; Krupova I; Grausova S; Koren P; Bezakova I; Grey E; Balaz M; Studena M; Kunova A; Torfs K; Trupl J; Korec S; Stopkova K; Krcmery V
Support Care Cancer; 1996 Nov; 4(6):427-34. PubMed ID: 8961473
[TBL] [Abstract][Full Text] [Related]
2. Risk factors, aetiology, therapy and outcome in 123 episodes of breakthrough bacteraemia and fungaemia during antimicrobial prophylaxis and therapy in cancer patients.
Spanik S; Trupl J; Kunova A; Drgona L; Salek T; Mardiak J; Kukuckova E; Studena M; Pichna P; Oravcova E; Grey E; Koren P; Svec J; Lacka J; Sufliarsky J; Krcmery V
J Med Microbiol; 1997 Jun; 46(6):517-23. PubMed ID: 9350206
[TBL] [Abstract][Full Text] [Related]
3. Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome.
Krupova I; Kaiserova E; Foltinova A; Kovacicova G; Kiskova M; Krchnakova A; Kunova A; Trupl J; West D; Krcmery V
J Chemother; 1998 Jun; 10(3):236-42. PubMed ID: 9669650
[TBL] [Abstract][Full Text] [Related]
4. Bacteremias caused by Escherichia coli in cancer patients - analysis of 65 episodes.
Krcmery V; Spanik S; Mrazova M; Trupl J; Grausova S; Grey E; Kukuckova E; Sulcova M; Krupova I; Koren P
Int J Infect Dis; 2002 Mar; 6(1):69-73. PubMed ID: 12044306
[TBL] [Abstract][Full Text] [Related]
5. Bacteremia and fungemia occurring during antimicrobial prophylaxis with ofloxacin in cancer patients: risk factors, etiology and outcome.
Spanik S; Trupl J; Ilavska I; Helpianska L; Drgona L; Demitrovicova A; Kukuckova E; Studena M; Pichna P; Oravcova E; Rusnakova V; Koren P; Lacka J; Krcmery V
J Chemother; 1996 Oct; 8(5):387-93. PubMed ID: 8957720
[TBL] [Abstract][Full Text] [Related]
6. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
Ugarte-Torres A; Villasis-Keever A; Hernández-Bribiesca ME; Crespo-Solis E; Ruiz-Palacios GM; Sifuentes-Osornio J; Ponce-De-León-Garduño A
Rev Invest Clin; 2006; 58(6):547-54. PubMed ID: 17432285
[TBL] [Abstract][Full Text] [Related]
7. Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.
Martino R; Subira M; Altés A; López R; Sureda A; Domingo-Albós A; Pericas R; Brunet S
Acta Haematol; 1998; 99(4):206-11. PubMed ID: 9644298
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance and outcome of polymicrobial Staphylococcus aureus bacteremia.
Park SY; Park KH; Bang KM; Chong YP; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
J Infect; 2012 Aug; 65(2):119-27. PubMed ID: 22410381
[TBL] [Abstract][Full Text] [Related]
9. Bacteremia in neutropenic versus nonneutropenic cancer patients: etiology and outcome in 401 episodes.
Mrázová-Studená M; Drgona L; Spánik S; Krúpová I; Baláz M; Pichna P; Koren P; Sufliarsky J; Mardiak J; Kunová A; Trupl J; Krcméry V
Neoplasma; 1997; 44(5):314-8. PubMed ID: 9473792
[TBL] [Abstract][Full Text] [Related]
10. [Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and microbiological analysis].
Falcone M; Carfagna P; Cassone M; Pistella E; Pavoni G; Nofroni I; Serra P; Venditti M
Ann Ital Med Int; 2002; 17(3):166-72. PubMed ID: 12402664
[TBL] [Abstract][Full Text] [Related]
11. Management of catheter-related Staphylococcus aureus bacteremia: when may sonographic study be unnecessary?
Pigrau C; Rodríguez D; Planes AM; Almirante B; Larrosa N; Ribera E; Gavaldà J; Pahissa A
Eur J Clin Microbiol Infect Dis; 2003 Dec; 22(12):713-9. PubMed ID: 14605943
[TBL] [Abstract][Full Text] [Related]
12. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
13. Breakthrough bacteraemic and fungaemic episodes during antimicrobial prophylaxis and therapy in cancer patients: analysis of risk factors, etiology, therapy and outcome in 123 episodes.
Spánik S; Krcméry V; Trupl J; Ilavská I; Hel'pianska L; Drgona L; Salek T; Mardiak J; Kukucková E; Studená M; Pichna P; Oravcová E; Grey E; Koren P; Minárik T; Lacka J; Sufliarsky J
Bratisl Lek Listy; 1996 Nov; 97(11):652-9. PubMed ID: 9117428
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution.
González-Barca E; Fernández-Sevilla A; Carratalá J; Grañena A; Gudiol F
Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):291-6. PubMed ID: 8781879
[TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
Gomez L; Garau J; Estrada C; Marquez M; Dalmau D; Xercavins M; Martí JM; Estany C
Cancer; 2003 Jan; 97(2):419-24. PubMed ID: 12518366
[TBL] [Abstract][Full Text] [Related]
16. Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis.
Spanik S; Trupl J; Kunova A; Botek R; Sorkovska D; Grey E; Studena M; Lacka J; Oravcova E; Krchnakova A; Rusnakova V; Svec J; Krupova I; Grausova S; Stopkova K; Koren P; Krcmery V
Scand J Infect Dis; 1997; 29(3):245-9. PubMed ID: 9255883
[TBL] [Abstract][Full Text] [Related]
17. Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group.
Bow EJ; Mandell LA; Louie TJ; Feld R; Palmer M; Zee B; Pater J
Ann Intern Med; 1996 Aug; 125(3):183-90. PubMed ID: 8686975
[TBL] [Abstract][Full Text] [Related]
18. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.
Bochud PY; Eggiman P; Calandra T; Van Melle G; Saghafi L; Francioli P
Clin Infect Dis; 1994 Jan; 18(1):25-31. PubMed ID: 8054434
[TBL] [Abstract][Full Text] [Related]
19. Bacteremia due to teicoplanin-resistant and vancomycin-susceptible Staphylococcus haemolyticus in seven patients with acute leukemia and neutropenia receiving prophylaxis with ofloxacin.
Krcméry V; Trupl J; Spanik S
Infection; 1997; 25(1):51-2. PubMed ID: 9039542
[No Abstract] [Full Text] [Related]
20. Polymicrobial bacteremia in cancer patients: analysis of risk factors, etiology and outcome in 214 episodes.
Ilavska I; Pichna P; Stopkova K; Grausova S; Krupova I; Oravcova E; Koren P; Lacka J; Studena M; Spanik S; Kunova A; Trupl J; Krcmery V
Int J Antimicrob Agents; 1996 Jul; 7(2):101-7. PubMed ID: 18611744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
